Selective Block of the Axillary Nerve in Postoperative Pain Management

Hillerod Hospital, Denmark

Status: Completed

Conditions: Pain, Postoperative

Treatments: Drug: Sodium chloride; Drug: ropivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT01463865

H-1-2011-057

Details and patient eligibility

About

In this study the investigators wish to compare the effect of a selective axillary nerve block to placebo in patients undergoing arthroscopic shoulder surgery.

It is the investigators hypothesis that the amount of morphine consumption in the first 4 hours postoperatively in the intervention group will be significant lower than in the placebo group.

Enrollment: 60 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects undergoing arthroscopic shoulder surgery
• Age between 18 and 80 years
• ASA 1-3
• BMI between 18 and 35 kg/m2
• Subjects which have given their written informed consent

Exclusion criteria

• Subjects unable to cooperate to the investigation
• Subjects not understanding or speaking danish
• Subjects allergic to intervention drugs
• Daily use of strong analgesics (morphine, oxycontine, ketogan)
• Alcohol or medicine misuse
• Failure of nerve block

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups, including a placebo group

Placebo

Placebo Comparator group

Description:

Sodium chloride

Treatment:

Drug: Sodium chloride

ropivacaine

Active Comparator group

Description:

Naropin

Treatment:

Drug: ropivacaine